These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 34446747)

  • 1. Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis.
    Wen YD; Zhu XS; Li DJ; Zhao Q; Cheng Q; Peng Y
    Sci Rep; 2021 Aug; 11(1):17170. PubMed ID: 34446747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing.
    Fan F; Zhang H; Dai Z; Zhang Y; Xia Z; Cao H; Yang K; Hu S; Guo Y; Ding F; Cheng Q; Zhang N
    Cell Oncol (Dordr); 2021 Aug; 44(4):917-935. PubMed ID: 34142341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
    Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X
    Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma.
    Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
    Aging (Albany NY); 2019 Dec; 11(24):12246-12269. PubMed ID: 31844032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Necroptosis-related Molecular Subtypes and Construction of Necroptosis-related Gene Signature for Glioblastoma Multiforme.
    Li Z; Jin Y; Que T; Zhang XA; Yi G; Zheng H; Yuan X; Wang X; Xu H; Nan J; Chen C; Wu Y; Huang G
    Curr Med Chem; 2024; 31(33):5417-5431. PubMed ID: 37539935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma.
    Prasad B; Tian Y; Li X
    Mol Neurobiol; 2020 Dec; 57(12):5235-5246. PubMed ID: 32875483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neutrophil extracellular traps-related gene signature predicts the prognosis of glioblastoma multiforme.
    Sun G; Liu W
    Folia Neuropathol; 2024; 62(1):59-75. PubMed ID: 38174685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Hypoxia Prognostic Signature in Glioblastoma Multiforme Based on Bulk and Single-Cell RNA-Seq.
    Ahmed YB; Ababneh OE; Al-Khalili AA; Serhan A; Hatamleh Z; Ghammaz O; Alkhaldi M; Alomari S
    Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses.
    Ye S; Yang B; Zhang T; Wei W; Li Z; Chen J; Li X
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk signature with four autophagy-related genes for predicting survival of glioblastoma multiforme.
    Wang Y; Zhao W; Xiao Z; Guan G; Liu X; Zhuang M
    J Cell Mol Med; 2020 Apr; 24(7):3807-3821. PubMed ID: 32065482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer.
    Hua T; Liu DX; Zhang XC; Li ST; Yan P; Zhao Q; Chen SB
    Front Immunol; 2023; 14():1151109. PubMed ID: 37063862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
    Lei CG; Jia XY; Sun WJ
    Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
    Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
    J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.
    Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE
    Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.